EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieVergleichsstudieOpen Access · CC BY 4.0

Effect of Initiation and Continuous Adherence to ARBs Versus ACEIs on Risk of Adjudicated Mild Cognitive Impairment or Dementia

Catherine G Derington, Ransmond O Berchie, Daniel O Scharfstein iD, Ryan M Andrews iD, Tom H Greene, Yizhe Xu, Jordan B King, Mark A Supiano, Joshua A Sonnen, Jeff Williamson, Nicholas M Pajewski iD, Jeremy J Pruzin und 2 weitere

The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences · 2025

DOI: 10.1093/gerona/glaf028 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2025. Verfasst von Catherine G Derington und 13 weiteren Autor:innen. Beteiligte Einrichtung: Intermountain Healthcare Department of Population Health Sciences, Spencer Fox Eccles School of Medicine, University of Utah, Salt Lake City, Utah, U…. Hauptthemen laut MEDLINE: Cognitive Dysfunction, Angiotensin-Converting Enzyme Inhibitors, Angiotensin Receptor Antagonists, Dementia. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCATS NIH HHS, NHLBI NIH HHS, NIA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Whether the differing mechanistic effects between angiotensin-2 receptor blockers (ARBs) and angiotensin-converting enzyme inhibitors (ACEIs) on the renin-angiotensin system translate to differential effects on clinical cognitive outcomes is unclear.

Methods

We employed an active comparator, new-user cohort study to emulate a target trial evaluating the per-protocol effect of initiating and continuously adhering to an ARB versus ACEI on adjudicated amnestic mild cognitive impairment (MCI) and probable dementia (PD) in the Systolic Blood Pressure Intervention Trial (SPRINT). Inverse probability of treatment and censoring weighted cumulative incidence functions accounted for confounding, the competing risk of death, adherence, and loss to follow-up.

Results

Of 9,361 SPRINT participants (mean age 67.1 ± 9.5 years, 36.7% female, 58.7% non-Hispanic White), 710 and 1,289 were new users of an ARB or ACEI. Overall, 291 (41.0%) ARB initiators and 854 (66.3%) ACEI initiators were nonadherent during follow-up. The IP-weighted 4-year probabilities of full adherence and being alive among ARB was 56.0% (95% CI: 52.2%–59.9%) and 30.5% (95% CI: 28.0%–33.1%) for ACEI. The 4-year weighted risk ratios (RR) for amnestic MCI/PD and for amnestic MCI/PD/death with initiation and full adherence to ARB versus ACEI were 0.94 (95% CI: 0.66–1.29) and 0.79 (95% CI: 0.58–1.06). The weighted 4-year weighted RR for all-cause death with ARB versus ACEI initiation and adherence was 0.36 (95% CI: 0.14-0.76).

Conclusions

In this target trial emulation of older adults at high risk for cardiovascular disease, there was insufficient evidence to conclude a beneficial effect of initiating and continuously adhering to an ARB versus ACEI on adjudicated clinical cognitive outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cognitive DysfunctionAngiotensin-Converting Enzyme InhibitorsAngiotensin Receptor AntagonistsDementiaHumansFemaleAgedMaleMiddle AgedHypertension

Stichwörter der Autor:innen

AntihypertensiveCognitionHypertensionMedicationTreatment

Substanzen

Angiotensin-Converting Enzyme InhibitorsAngiotensin Receptor Antagonists

Autor:innen und Institutionen

  • Intermountain Healthcare Department of Population Health Sciences, Spencer Fox Eccles School of Medicine, University of Utah, Salt Lake City, Utah, USA.
  • Department of Epidemiology, Boston University School of Public Health, Boston, Massachusetts, USA.
  • Institute for Health Research, Kaiser Permanente Colorado, Aurora, Colorado, USA.
  • Geriatrics Division, Spencer Fox Eccles School of Medicine, University of Utah, Salt Lake City, Utah, USA.
  • University of Utah Center on Aging, Salt Lake City, Utah, USA.
  • Departments of Pathology, Neurology and Neurosurgery, McGill University, Montréal, Québec, Canada.

ORCID-Profile: Daniel O Scharfstein, Ryan M Andrews, Nicholas M Pajewski, Jordana B Cohen

Förderung

  • NCATS NIH HHS
  • NHLBI NIH HHS
  • NIA NIH HHS
  • American Heart Association Bugher
  • NIDDK NIH HHS
  • National Institute on Aging
  • National Heart, Lung, and Blood Institute
  • National Center for Advancing Translational Sciences

Zitieren

APA

Derington, C. G., Berchie, R. O., Scharfstein, D. O., Andrews, R. M., Greene, T. H., Xu, Y., King, J. B., Supiano, M. A., Sonnen, J. A., Williamson, J., Pajewski, N. M., Pruzin, J. J., Cohen, J. B., & Bress, A. P. (2025). Effect of Initiation and Continuous Adherence to ARBs Versus ACEIs on Risk of Adjudicated Mild Cognitive Impairment or Dementia. The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences. https://doi.org/10.1093/gerona/glaf028

Vancouver

Derington CG, Berchie RO, Scharfstein DO, Andrews RM, Greene TH, Xu Y, et al. Effect of Initiation and Continuous Adherence to ARBs Versus ACEIs on Risk of Adjudicated Mild Cognitive Impairment or Dementia. The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences. 2025. doi:10.1093/gerona/glaf028

BibTeX
@article{Derington2025,
  author = {Derington, Catherine G and Berchie, Ransmond O and Scharfstein, Daniel O and Andrews, Ryan M and Greene, Tom H and Xu, Yizhe and King, Jordan B and Supiano, Mark A and Sonnen, Joshua A and Williamson, Jeff and Pajewski, Nicholas M and Pruzin, Jeremy J and Cohen, Jordana B and Bress, Adam P},
  title = {Effect of Initiation and Continuous Adherence to ARBs Versus ACEIs on Risk of Adjudicated Mild Cognitive Impairment or Dementia},
  journal = {The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences},
  year = {2025},
  doi = {10.1093/gerona/glaf028}
}
Kostenlos starten →